283 related articles for article (PubMed ID: 12649564)
21. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
22. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F
Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
Ding XQ; Chen D; Håkanson R
Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of the lectin wheat germ agglutinin on the binding of 125I-CCK-8s to the CCK-A and -B receptors of AR42J cells.
Damm I; Mikkat U; Kirchhoff F; Böckmann S; Jonas L
Pancreas; 2004 Jan; 28(1):31-7. PubMed ID: 14707727
[TBL] [Abstract][Full Text] [Related]
25. CCK, bombesin, and carbachol stimulate c-fos, c-jun, and c-myc oncogene expression in rat pancreatic acini.
Lu L; Logsdon CD
Am J Physiol; 1992 Sep; 263(3 Pt 1):G327-32. PubMed ID: 1415544
[TBL] [Abstract][Full Text] [Related]
26. Reduced cholecystokinin receptor phosphorylation and restored signalling in protein kinase C down-regulated rat pancreatic acinar cells.
Smeets RL; Rao RV; van Emst-de Vries SE; De Pont JJ; Miller LJ; Willems PH
Pflugers Arch; 1998 Feb; 435(3):422-8. PubMed ID: 9426300
[TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin and gastrin peptides stimulate ODC activity in a rat pancreatic cell line.
Scemama JL; De Vries L; Pradayrol L; Seva C; Tronchere H; Vaysse N
Am J Physiol; 1989 May; 256(5 Pt 1):G846-50. PubMed ID: 2719109
[TBL] [Abstract][Full Text] [Related]
28. Exogenous CCK and gastrin stimulate pancreatic exocrine secretion via CCK-A but also via CCK-B/gastrin receptors in the calf.
Le Dréan G; Le Huërou-Luron I; Gestin M; Desbois C; Romé V; Bernard C; Dufresne M; Moroder L; Gully D; Chayvialle JA; Fourmy D; Guilloteau P
Pflugers Arch; 1999 Jun; 438(1):86-93. PubMed ID: 10370091
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cholecystokinin-mediated amylase secretion by leptin in rat pancreatic acinar tumor cell line AR42J.
Harris DM; Flannigan KL; Go VL; Wu SV
Pancreas; 1999 Oct; 19(3):224-30. PubMed ID: 10505752
[TBL] [Abstract][Full Text] [Related]
30. Cholecystokinin-B/gastrin receptor signaling pathway involves tyrosine phosphorylations of p125FAK and p42MAP.
Taniguchi T; Matsui T; Ito M; Murayama T; Tsukamoto T; Katakami Y; Chiba T; Chihara K
Oncogene; 1994 Mar; 9(3):861-7. PubMed ID: 8108129
[TBL] [Abstract][Full Text] [Related]
31. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
32. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain.
Ge J; Long SK; Kilpatrick IC
Eur J Pharmacol; 1998 Mar; 345(2):163-70. PubMed ID: 9600632
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of exocrine pancreatic insufficiency in streptozotocin-induced type 1 diabetes mellitus.
Patel R; Shervington A; Pariente JA; Martinez-Burgos MA; Salido GM; Adeghate E; Singh J
Ann N Y Acad Sci; 2006 Nov; 1084():71-88. PubMed ID: 17151294
[TBL] [Abstract][Full Text] [Related]
34. Molecular cloning of an unusual bicistronic cholecystokinin receptor mRNA expressed in chicken brain: a structural and functional expression study.
Nilsson IB; Svensson SP; Monstein HJ
Regul Pept; 2003 Jun; 114(1):37-43. PubMed ID: 12763638
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Jensen RT; Mantey SA; Bell RH
Gastroenterology; 1994 Oct; 107(4):1135-46. PubMed ID: 7523219
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines.
Monstein HJ; Ohlsson B; Axelson J
Scand J Gastroenterol; 2001 Jul; 36(7):738-43. PubMed ID: 11444473
[TBL] [Abstract][Full Text] [Related]
37. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
[TBL] [Abstract][Full Text] [Related]
38. CCK(B)/gastrin receptor mediates synergistic stimulation of DNA synthesis and cyclin D1, D3, and E expression in Swiss 3T3 cells.
Zhukova E; Sinnett-Smith J; Wong H; Chiu T; Rozengurt E
J Cell Physiol; 2001 Dec; 189(3):291-305. PubMed ID: 11748587
[TBL] [Abstract][Full Text] [Related]
39. Antagonistic effect of CCK-8 on morphine-inhibited electrical and contractile activities of rat jejunum in vitro.
Xu MY; Yang DX; Wang SZ; Jin HB; Zou XH; Yang XP; Han JS
Sheng Li Xue Bao; 1998 Aug; 50(4):469-73. PubMed ID: 11324560
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
